Physician profile
Mark B Moeller
NPI 1053304097
$788.78
in general payments reported to CMS, 2019-2025
16 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $45.04 · 2021: $29.59 · 2022: $37.95 · 2023: $87.11 · 2024: $119 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $254.84 | 2019-2024 | Otezla, Repatha |
| Novo Nordisk INC | $112.20 | 2023-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $95.45 | 2019-2025 | Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $67.82 | 2024-2025 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.53 | 2019 | |
| Abbvie INC. | $37.77 | 2023-2025 | |
| Abbott Laboratories | $35.36 | 2021-2023 | Amplatzer Amulet |
| Edwards Lifesciences Corporation | $20.29 | 2024 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $18.02 | 2023 | Intellis Adaptivestim |
| Lilly USA, LLC | $17.76 | 2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $17.40 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $15.26 | 2025 | |
| Daiichi Sankyo INC. | $15.19 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.10 | 2022 | |
| Boston Scientific Corporation | $13.48 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Moeller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.